Search Results 321-330 of 16730 for Imiglucerase
The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...
About this study. This phase II trial studies how well eribulin mesylate works in treating patients with osteosarcoma that has come back after treatment ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20381052. Home; Pharmacogenomics ...
Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.
This study will examine the effect intravenously administered rigosertib has on the relationship between bone marrow blasts response and overall survival in ...
Charles J. Bruce, M.B., Ch.B., a Mayo Clinic cardiologist, develops technologies that expand how cardiovascular care is delivered.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.